PolarityTE: Will This Biotech Be The Next Amazon Or Tesla?
Jeff Dyer and Hal Gregersen, CONTRIBUTORS -We write about innovation based on research from The Innovator’s DNA. Opinions expressed by Forbes Contributors are their own. By Jeff Dyer Did Johns Hopkins dropouts just deliver the paradigm shift in disruptive biotechnology, a new model for public launch, and the beginning of a biotech boom? “You realize this is irreversible — right?” Were the last words that Drs. Denver Lough MD, PhD and Ned Swanson MD heard as they handed in their resignations from the world-renowned Johns Hopkins Hospital Department of Plastic and Reconstructive Surgery. It was really hard to walk away — I had put 17 years into becoming a plastic and reconstructive surgeon and was finally in the foremost program at the world’s greatest hospital, surrounded by amazing leaders in the field,” said Lough. “How could I possibly justify giving that up to everyone who had sacrificed so much for me to get there. But on December 1st of 2016, Lough and Swanson...